In this episode featuring faculty from the United States and Europe, Aadia I. Rana, MD, and Laurence Slama, MD, PhD, discuss the subtleties of deciding among HIV treatment options in people with adherence challenges.Listen as they debate the potential risks and benefits of long-acting ART in this population, considerations for people with viremia or resistance, recommendations concerning proviral DNA genotyping, and how to interpret guidelines and provide truly patient-centered care. PresentersAadia I. Rana, MDProfessor of MedicineDivision of Infectious DiseasesUniversity of Alabama at Birmingham Heersink School of MedicineBirmingham, AlabamaLaurence Slama, MD, PhDDoctorDepartment of Infectious DiseasesHôtel Dieu University HospitalUniversity Paris CitéParis, FranceFollow along with the slides here.See the full program here.Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast channel on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related